This study confirmed the neuroprotective effects of Semax against MPTP-induced lesions of the brain dopaminergic system in a Parkinson's disease model. Semax treatment preserved dopaminergic neuron integrity and function, reinforcing its potential as a neuroprotectant for dopamine-related neurodegeneration.
Levitskaya, N G; Sebentsova, E A; Andreeva, L A; Alfeeva, L Yu; Kamenskii, A A; Myasoedov, N F